Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -1927.32% is 218% below its 5-year average of -605.40%, near the high end of its 5-year range (-1869700.00%–28.52%).
9.73% below its 12-month average of -1756.39%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 7.89%.
OPERATING MARGIN
-1927.32%
OPERATING MARGIN AVG TTM
-1756.39%
OPERATING MARGIN AVG 3Y
-1186.34%
OPERATING MARGIN AVG 5Y
-605.40%
OPERATING MARGIN AVG 10Y
-598.26%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-9.73%
CURRENT VS 3Y AVG
-62.46%
CURRENT VS 5Y AVG
-218.36%
CURRENT VS 10Y AVG
-222.15%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 747 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
AC Immune S.A.
Market Cap
$261.05M
Operating Margin
-1927.32%
TTM Avg
-1756.39%
3Y Avg
-1186.34%
5Y Avg
-605.40%
Market Cap
$258.23M
Operating Margin
-4.24%
TTM Avg
-7.03%
3Y Avg
-2.53%
5Y Avg
-5.01%
Market Cap
$261.24M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-1307.00%
5Y Avg
-871.33%
Market Cap
$251.69M
Operating Margin
-13.78%
TTM Avg
-1055.13%
3Y Avg
-2810.33%
5Y Avg
-1873.55%
Market Cap
$250.99M
Operating Margin
-38.88%
TTM Avg
-71.50%
3Y Avg
-611.78%
5Y Avg
-463.72%
Market Cap
$263.05M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-2313.03%
5Y Avg
-2198.82%
Market Cap
$266.05M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-5599.55%
5Y Avg
-3879.66%
Market Cap
$266.44M
Operating Margin
-59.23%
TTM Avg
-35.16%
3Y Avg
-14.58%
5Y Avg
-11.13%
Market Cap
$266.50M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AC Immune S.A. (ACIU) | $261.05M | -1927.32% | -1756.39% | -1186.34% | -605.40% |
| Anika Therapeutics, Inc. (ANIK)vs › | $258.23M | -4.24% | -7.03% | -2.53% | -5.01% |
| Palisade Bio, Inc. (PALI)vs › | $261.24M | 0.00% | 0.00% | -1307.00% | -871.33% |
| Century Therapeutics, Inc. (IPSC)vs › | $251.69M | -13.78% | -1055.13% | -2810.33% | -1873.55% |
| Sol-Gel Technologies Ltd. (SLGL)vs › | $250.99M | -38.88% | -71.50% | -611.78% | -463.72% |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $263.05M | 0.00% | 0.00% | -2313.03% | -2198.82% |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $266.05M | 0.00% | 0.00% | -5599.55% | -3879.66% |
| OraSure Technologies, Inc. (OSUR)vs › | $266.44M | -59.23% | -35.16% | -14.58% | -11.13% |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $266.50M | 0.00% | 0.00% | 0.00% | 0.00% |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $267.03M | -775.98% | -556.52% | -379.20% | -295.79% |
Gross Margin
100.0%
Operating Margin
-1927.3%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 7.89% |
| 2026-03-31 | -1321.54% |
| 2025-12-31 | -4262.13% |
| 2025-09-30 | -1721.62% |
| 2025-06-30 | -1484.53% |
| 2025-03-31 | -1956.57% |
| 2024-12-31 | -1637.47% |
| 2024-09-30 | 28.52% |
| 2024-06-30 | -3051.09% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | -23.92% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | -1869700.00% |
| 2022-09-30 | -342.22% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | -2061.97% |
| 2020-09-30 | -1674.53% |
| 2020-06-30 | 1448.48% |
| 2020-03-31 | -59.46% |
| 2019-12-31 | -2188.72% |
| 2019-09-30 | 53.81% |
| 2019-06-30 | -977.76% |
| 2019-03-31 | 80.16% |
| 2018-12-31 | -1032.64% |
| 2018-09-30 | -528.03% |
| 2018-06-30 | -570.51% |
| 2018-03-31 | -776.54% |
| 2017-12-31 | 19.41% |
| 2017-09-30 | -897.58% |
| 2017-06-30 | -1096.02% |
| 2017-03-31 | -390.53% |
| 2016-12-31 | -633.71% |
| 2016-09-30 | -605.85% |
| 2016-06-30 | 62.45% |
| 2016-03-31 | -1187.68% |
| 2015-12-31 | -2001.90% |
| 2015-09-30 | 79.30% |
| 2015-06-30 | 61.73% |
| 2015-03-31 | -1393.62% |
| 2014-12-31 | 76.12% |
| 2014-09-30 | -2376.06% |
| 2014-06-30 | -113.87% |
| 2014-03-31 | -113.87% |
